Recent independent research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2026 revealed a strong link between gum disease bacteria and the hardening of heart valves, specifically calcific aortic valve stenosis (CAVS). The study focused on Porphyromonas gingivalis (P. gingivalis), a key bacterium in gum inflammation, and found that repeated exposure to this bacteria led to its accumulation in the aortic valves of mice, increasing calcification and symptoms of aortic stenosis. Preventive antibiotic treatment was shown to reduce these effects.
The mechanism identified involves P. gingivalis activating interleukin-1 beta (IL-1b), an inflammation-spurring protein. Further testing demonstrated that genetically deleting IL-1b in mice significantly reduced calcification and valve symptoms, even in the presence of the bacteria. This suggests that the inflammatory pathway plays a crucial role in the damage and represents a potential therapeutic target, possibly through existing IL-1b inhibiting drugs.
While the findings, primarily from animal models, do not yet confirm direct causation in humans, researchers have initiated a clinical study to further investigate this link. Chenyang Li, M.D., a co-lead author, emphasized that good oral hygiene is essential for overall health and may benefit cardiovascular health. Eduardo Sanchez, M.D., M.P.H., FAHA, of the American Heart Association, highlighted the growing evidence connecting oral and heart health, advocating for dentists to be important partners in identifying health conditions early.
CAVS, a condition where the aortic valve thickens and calcifies, restricts blood flow and can lead to severe symptoms and premature death, with valve replacement surgery being the only established treatment. Currently, no medications prevent or slow CAVS progression, making the identification of modifiable risk factors like oral bacteria clinically significant. Researchers hope these findings stimulate further research into new preventive and therapeutic approaches for CAVS.
